WallStreetZenWallStreetZen

NASDAQ: AQST
Aquestive Therapeutics Inc Stock Ownership - Who owns Aquestive Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aquestive Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel BarberPresident and CEO2026-05-158,257$4.29
$35.41kSell
Melina CioffiSVP Regulatory Affairs2026-05-151,667$4.17
$6.95kSell
Lori J. BraenderCorporate Secretary2026-05-07135,690$4.23
$573.97kSell
Lori J. BraenderCorporate Secretary2026-05-0576,147$4.18
$318.29kSell
Daniel BarberPresident and CEO2026-05-05335,922$4.18
$1.40MSell
Cassie JungChief Operating Officer2026-05-0572,734$4.18
$304.03kSell
Peter E. BoydChief People Officer2026-05-0556,778$4.18
$237.33kSell
A. Ernest Toth Jr.Chief Financial Officer2026-05-0592,652$4.18
$387.29kSell
Melina CioffiSVP Regulatory Affairs2026-03-1025,311$4.17
$105.62kSell
Daniel BarberPresident and CEO2026-03-10180,677$4.17
$753.97kSell

1 of 3

AQST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AQST insiders and whales buy or sell their stock.

AQST Shareholders

What type of owners hold Aquestive Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bratton Capital Management LP7.82%9,810,958$41.30MInstitution
Blackrock Inc5.99%7,509,071$31.61MInstitution
Rtw Investments LP5.92%7,426,471$31.27MInstitution
Vanguard Capital Management LLC3.54%4,443,698$18.71MInstitution
Federated Hermes Inc2.34%2,940,339$12.38MInstitution
Balyasny Asset Management LP2.31%2,900,570$12.21MInstitution
State Street Corp2.03%2,546,191$10.72MInstitution
Samsara Biocapital LLC1.99%2,500,000$10.53MInstitution
Geode Capital Management LLC1.92%2,408,191$10.14MInstitution
Bank Of America Corp1.92%2,405,050$10.13MInstitution

1 of 3

AQST vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AQST57.21%5.93%Net SellingNet Selling
TLRY8.95%17.41%Net BuyingNet Selling
IRWD73.10%26.90%Net SellingNet Selling
EOLS69.33%28.02%Net SellingNet Selling
EBS45.88%54.12%Net SellingNet Selling
View Top Pharmaceutical Stocks

Aquestive Therapeutics Stock Ownership FAQ

Who owns Aquestive Therapeutics?

Aquestive Therapeutics (NASDAQ: AQST) is owned by 57.21% institutional shareholders, 5.93% Aquestive Therapeutics insiders, and 36.86% retail investors. Douglas K. Bratton is the largest individual Aquestive Therapeutics shareholder, owning 1.96M shares representing 1.57% of the company. Douglas K. Bratton's Aquestive Therapeutics shares are currently valued at $8.19M.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.